Table 1.

Absolute plasma concentrations of apixaban, rivaroxaban, and ticagrelor during 6 h of haemoperfusion. Results represent mean ± SD, n = 5.

	Apixaban (ng/mL)		Rivaroxaban (ng/mL)		Ticagrelor (ng/mL)
Time (min)	Control	Treatment	Control	Treatment	Control	Treatment
0	220.4 ± 11.1	206.8 ± 18.0	449.8 ± 46.0	437.3 ± 47.1	989.6 ± 93.0	964.8 ± 120.8
15	218.3 ± 7.9	86.6 ± 5.2	430.4 ± 34.3	189.4 ± 22.0	924.6 ± 50.8	473.8 ± 97.7
30	219.7 ± 22.0	38.4 ± 6.6	423.1 ± 29.0	83.6 ± 6.6	960.8 ± 42.7	362.2 ± 56.4
45	226.5 ± 24.1	16.5 ± 2.8	432.4 ± 32.8	40.4 ± 8.2	929.8 ± 51.5	301.4 ± 29.8
60	214.3 ± 13.3	7.6 ± 1.3	425.4 ± 27.0	20.9 ± 5.2	943.8 ± 56.1	241.6 ± 28.8
90	211.2 ± 10.6	3.3 ± 2.3	426.3 ± 27.3	7.8 ± 2.0	915.6 ± 60.7	166.4 ± 17.2
120	213.9 ± 9.5	1.3 ± 1.0	427.6 ± 28.2	4.7 ± 1.5	911.8 ± 79.5	129.4 ± 15.6
180	214.9 ± 9.1	0.8 ± 0.1	431.8 ± 26.2	3.2 ± 0.9	893.4 ± 54.0	86 ± 11.3
270	214.7 ± 9.3	0.6 ± 0.1	445 ± 20.5	2.5 ± 0.8	948 ± 92.8	61.8 ± 6.2
360	223.2 ± 12.7	0.5 ± 0.1	454.2 ± 15.2	2.1 ± 0.4	926.8 ± 45.6	49.3 ± 4.4